Our global network of state-of-the-art laboratories offer Central Laboratories located in Valencia (CA, United States), Edinburgh (United Kingdom), Mumbai (India), Singapore, Beijing (China) and Tokyo (Japan) with partner laboratories in South America and South Africa. Our Centers of Excellence for Vaccines, Genomics and Bioanalytical/ADME are strategically located to offer worldwide testing solutions.
We provide cutting-edge technologies, including detection of SARSCoV-2 virus and antibodies; vaccine neutralization testing; immunologic profiling (flow cytometry and cytokine detection); immunogenicity analysis; bioanalytic techniques for pharmacodynamics and pharmacokinetics and human and SARS-CoV-2 virus genomic analysis. Q2 Solutions has the global capacity and high-quality infrastructure to support your COVID-19 clinical trials.
Global regulatory readiness for COVID-19 sample handling and testing. Representative laboratory services offered:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q2 Solutions is a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions. With a relentless focus on quality and innovation, Q2 Solutions uses its global experience and scientific expertise to transform science and data into actionable medical insights that help customers improve human health.